News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sohn Catherine A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 08/15/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1585, valued at
$171.5k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/27/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 47,000 options to buy
@ $4.19, valued at
$196.9k
|
|
| 03/27/2023 |
3
| Sohn Catherine A. (Director) has filed a Form 3 on Altimmune, Inc. |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.7, valued at
$34k
|
|
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,246 shares
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $23.25, valued at
$581.3k
|
|
| 11/06/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Sold 4,500 shares
@ $156, valued at
$702k
Sold 8,000 shares
@ $152, valued at
$1.2M
Exercised 8,000 options to buy
@ $46.83, valued at
$374.6k
Exercised 4,500 options to buy
@ $81.76, valued at
$367.9k
|
|
| 10/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 8,303 options to buy
@ $0 |
|
| 05/29/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 6,000 shares
@ $10.99, valued at
$65.9k
Exercised 6,000 restricted stock units
@ $0 |
|
| 05/26/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $6.22, valued at
$155.5k
|
|
| 05/22/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 11,000 options to buy
@ $4.2, valued at
$46.2k
|
|
| 01/21/2020 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 1,000 shares
@ $4.87, valued at
$4.9k
|
|
| 10/17/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Granted 2,200 options to buy
@ $0 |
|
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Granted 22,000 options to buy
@ $8.11, valued at
$178.4k
|
|
| 08/23/2019 |
3
| Sohn Catherine A. (Director) has filed a Form 3 on Axcella Health Inc. |
| 08/12/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,920 shares
@ $0
Sold 726 shares
@ $135.6503, valued at
$98.5k
Granted 4,805 options to buy
@ $137.12, valued at
$658.9k
|
|
| 05/30/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Exercised 4,240 shares
@ $9.91, valued at
$42k
Exercised 4,240 restricted stock units
@ $0
Granted 6,000 options to buy
@ $0 |
|
| 05/28/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $16.27, valued at
$406.8k
|
|
| 01/11/2019 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on LANDEC CORP \CA\|
Txns:
| Bought 1,000 shares
@ $11.23, valued at
$11.2k
|
|
| 08/13/2018 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,495 shares
@ $0
Sold 660 shares
@ $176.6108, valued at
$116.6k
Granted 3,735 options to buy
@ $177.73, valued at
$663.8k
|
|
| 07/23/2018 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Bought 2,500 shares
@ $23, valued at
$57.5k
|
|
|
|
|